China probes drugmakers over production methods

Three Chinese drugmakers are under investigation for crimes including using counterfeit medicines, the industry watchdog said, as China cracks down on shoddy practices in the world’s second-biggest drugs market. The China Food and Drug Administration said it was investigating Hebei Yongfeng Yaoye, a subsidiary of Hong Kong-listed CSPC Pharmaceutical Group, as well as Gansu Dadeli Pharmaceutical and Guizhou Shouxian Pharmaceutical. China is pushing an ambitious program of healthcare reforms to improve its home-made medicines, and has vowed to crack down on poor quality drugs.

Continued here:
China probes drugmakers over production methods